Bioventus BVS
NASDAQ BVS
$13.64 -0.19 (-1.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026)

Bioventus' (BVS) quarterly Income from Non-Controlling Interests came in at $3.0 million in Q2 2026, up 40.89% on a YoY basis from $2.1 million in Q2 2025, and up 258.22% quarter-over-quarter from $833000.0 in Q1 2026.

Analysis

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Bioventus (BVS) has reported Income from Non-Controlling Interests for 7 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 40.89% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $7.1 million (up 1034.08% YoY), and the FY2025 full-year result was $4.5 million, up 141.58% from the prior year.
  • Income from Non-Controlling Interests grew to $3.0 million in Q2 2026 per BVS's latest filing, from $833000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $3.0 million in Q2 2026 and bottomed at -$28.2 million in Q4 2022.
  • Historically, Income from Non-Controlling Interests has averaged -$3.8 million across 5 years, with a median of -$906000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests slumped 2069.38% in 2022, then jumped 1964.06% in 2025.
  • Over 5 years, Income from Non-Controlling Interests stood at -$8.2 million in 2022, then soared by 81.07% to -$1.6 million in 2023, then jumped by 91.79% to -$128000.0 in 2024, then surged by 1964.06% to $2.4 million in 2025, then increased by 25.06% to $3.0 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $3.0 million, $833000.0, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 6.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 9.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -2.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -500,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 900,000.00
10 Bioventus 923.70 Mn 894.24 Mn 105.67 Mn 2.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 2.98 Mn
Mar 28, 2026 833,000.00
Dec 31, 2025 2.39 Mn
Sep 27, 2025 851,000.00
Jun 28, 2025 2.12 Mn
Mar 29, 2025 -685,000.00
Dec 31, 2024 -128,000.00
Sep 28, 2024 -683,000.00
Jun 29, 2024 -8.62 Mn
Mar 30, 2024 -1.49 Mn
Dec 31, 2023 -1.56 Mn
Sep 30, 2023 -1.49 Mn
Jul 1, 2023 -1.05 Mn
Apr 1, 2023 -20.36 Mn
Dec 31, 2022 -8.24 Mn
Oct 1, 2022 -28.20 Mn
Jul 2, 2022 -762,000.00
Apr 2, 2022 -3.53 Mn
Dec 31, 2021 -1.53 Mn
Oct 2, 2021 -1.30 Mn